Ribomic (TSE:4591) Total Liabilities: 円135.09 Mil (As of Mar. 2026)


TSE:4591 Ribomic Inc TSE:4591
25 GF Score
Price 円61.00
! 3 Warning Signs
View Full Analysis

What is Ribomic Total Liabilities?

Ribomic TSE:4591 25 Total Liabilities is 円135.09 Mil as of Mar. 2026. GuruFocus rates TSE:4591 with a GF Score™ of 25/100. The stock has 3 warning signs investors should review.

Ribomic's Total Liabilities for the quarter that ended in Mar. 2026 was 円135.09 Mil.

Ribomic's quarterly Total Liabilities declined from Mar. 2025 (円142.21 Mil) to Sep. 2025 (円131.67 Mil) but then increased from Sep. 2025 (円131.67 Mil) to Mar. 2026 (円135.09 Mil).

Ribomic's annual Total Liabilities declined from Mar. 2024 (円155.81 Mil) to Mar. 2025 (円142.21 Mil) and declined from Mar. 2025 (円142.21 Mil) to Mar. 2026 (円135.09 Mil).

Ribomic Total Liabilities Historical Data

* Premium members only.

The historical data trend for Ribomic's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic Total Liabilities Chart

Ribomic Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 260.53 199.30 155.81 142.21 135.09

Ribomic Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 155.81 108.56 142.21 131.67 135.09
TSE:4591
25GF Score
Ribomic Inc TSE:4591
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ribomic Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ribomic's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=135.093+(0+-0.00099999999997635
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=135.09

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=2976.215-2841.123
=135.09

Ribomic's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=135.093+(0+-0.00099999999997635
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=135.09

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2976.215-2841.123
=135.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円135.09 Mil mean?
Ribomic (TSE:4591) has a Total Liabilities of 円135.09 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ribomic and its competitors.
Is Ribomic's Total Liabilities too high?
Ribomic's current Total Liabilities is 円135.09 Mil. Overall, Ribomic has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Ribomic's Total Liabilities compare to VRTX and REGN?
Ribomic's Total Liabilities of 円135.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ribomic and its competitors. Ribomic's current Total Liabilities is 円135.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ribomic stock overvalued right now?
Ribomic (TSE:4591) has a current Total Liabilities of 円135.09 Mil. The current Total Liabilities is 円135.09 Mil. Ribomic's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Ribomic (TSE:4591), the current Total Liabilities is 円135.09 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
25GF Score

Get the complete analysis for TSE:4591

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円61.00
Price